Skip to main content
. 2021 Feb 28;22(5):2449. doi: 10.3390/ijms22052449
RA Rheumatoid arthritis
DMARDs Disease-modifying antirheumatic drugs
JAK Janus kinases
STAT Signal transducers and activators of transcription
PE Pulmonary embolism
DVT Deep vein thrombosis
IFN Interferon
IL Interleukin
JH JAK homology
SOCS Suppressor of cytokine signaling
GM-CSF Granulocyte-macrophage colony-stimulating factor
MACE Major adverse cardiovascular events
VTE Venous thromboembolic event